Compugen reported $2.33M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
aTyr Pharma USD 4.8M 130K Sep/2025
Clal Biotechnology ILS 3.31M 513K Dec/2022
Compugen USD 2.33M 50K Sep/2025
RedHill Biopharma USD 4.48M 1.52M Mar/2024